Experienced in Hairy Cell Leukemia (HCL)

Christoph C. Zielinski

Vienna, AT 
Experienced in Hairy Cell Leukemia (HCL)
Vienna, AT 
OverviewLocationsClinical Research

Overview

Christoph Zielinski practices in Vienna, Austria. Dr. Zielinski is rated as an Experienced expert by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Venous Thromboembolism (VTE), Breast Cancer, Anaplastic Thyroid Cancer, and Lung Cancer.

His clinical research consists of co-authoring 197 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hairy Cell Leukemia (HCL).

Gender
Male

Locations

Vienna, Austria
Other Locations
Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1b/2 Open-Label Study With Randomization in Phase 2 of IMU-131 HER2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
A Phase 1b/2 Open-Label Study With Randomization in Phase 2 of IMU-131 HER2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Biological, Drug
Study Drugs: IMU-131, Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine
Study Phase: Phase 1/Phase 2

197 Total Publications

11th Immunotherapy of Cancer conference (ITOC): A meeting report.
11th Immunotherapy of Cancer conference (ITOC): A meeting report.
Journal: Human vaccines & immunotherapeutics
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zielinski's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 23 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile